BioNJ is involved in ensuring that New Jersey retains its leading position as a center of global life sciences by facilitating the industry’s development.
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.